Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Induction Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117659009A reveals a chiral induction method for moxifloxacin side chain. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103319487B reveals a low-cost Sitagliptin route using L-phenylglycinol. Achieve high purity and scalable API manufacturing with reduced noble metal dependency.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.